Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00782366 · ClinicalTrials.gov registry record
Predictive Genetic Risk Assessment Trial
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 26
- Enrollment target
NCT00782366: Completed study, sponsored by Mayo Clinic.
NCT00782366 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00782366 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
This proof-of-principle clinical trial at Mayo Clinic studies how patients and their physicians understand and utilize predictive genetic risk assessment. A critical goal of this clinical trial is to understand how individual patients and their doctors perceive and respond to genetic risk information that is largely uncertain.
Interventions
- GENETIC SNP analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-01 |
What the finished NCT00782366 record still lists
NCT00782366 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which SNP analysis is the first listed.
NCT00782366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00782366 about?
NCT00782366 is a clinical study titled "Predictive Genetic Risk Assessment Trial". This proof-of-principle clinical trial at Mayo Clinic studies how patients and their physicians understand and utilize predictive genetic risk assessment. A critical goal of this clinical trial is to understand how individual patients and their doctors perceive and respond to genetic risk informatio...
What is the current status of trial NCT00782366?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2008-03. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00782366?
The interventions under investigation include: SNP analysis (GENETIC).
Who is sponsoring clinical trial NCT00782366?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia